XML 35 R5.htm IDEA: XBRL DOCUMENT v3.25.2
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
 12 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Operating expenses:    
Research and development expenses $ (909,771) $ (880,193)
General and administrative expenses (2,111,265) (1,661,379)
Total operating expenses (3,021,036) (2,541,572)
Other income (expense):    
Interest income 24,915 53,495
Other expense, net (262,848) (294,201)
Total other expense, net (237,933) (240,706)
Loss before tax expense (3,258,969) (2,782,278)
Income tax expense
Net Loss (3,258,969) (2,782,278)
Other comprehensive loss    
Foreign currency translation gain, net of taxes 218,346 319,324
Total comprehensive loss $ (3,040,623) $ (2,462,954)
Loss per share:    
Basic (in Dollars per share) [1] $ (0.16) $ (0.14)
Diluted (in Dollars per share) [1] $ (0.16) $ (0.14)
Weighted average number of shares of common stock in computing net loss per share    
Basic (in Shares) [1] 20,525,699 20,000,000
Diluted (in Shares) [1] 20,525,699 20,000,000
[1] Giving retroactive effect to the 5 for 1 reverse share split effected on October 15, 2024.